Regeneron Plays It Safe With Eylea, Aims To Undercut Lucentis
This article was originally published in The Pink Sheet Daily
Executive Summary
Regeneron has designed the launch strategy of its bimonthly wet AMD injection Eylea to head off any reimbursement issues.